Yonsei University
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 1885-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.yonsei.ac.kr
Treatment Response of Maintenance Dose of Proton Pump Inhibitor in Patients With Nonerosive Gatroesophageal Reflux Disease
Not Applicable
Completed
- Conditions
- Non-erosive Gatroesophageal Reflux Disease
- Interventions
- Drug: PPI
- First Posted Date
- 2018-02-19
- Last Posted Date
- 2020-01-02
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 62
- Registration Number
- NCT03436914
- Locations
- 🇰🇷
Yonsei university College of Medicine, Seoul, Korea, Republic of
Phase IV Study to Evaluate the Effects of Statin Monotherapy or Statin / Ezetimibe Combination Therapy on Hepatic Steatosis in Patients With Hyperlipidemia and Nonalcoholic Fatty Liver Disease
Phase 4
Completed
- Conditions
- Nonalcoholic Fatty Liver DiseaseDyslipidemias
- Interventions
- Drug: Rosuvastatin/ezetimibe combinationDrug: Rosuvastatin
- First Posted Date
- 2018-02-15
- Last Posted Date
- 2021-07-09
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 64
- Registration Number
- NCT03434613
- Locations
- 🇰🇷
Yonsei University College of Medicine, Department of Internal Medicine, Division of Endocrinology, Severance Hospital, Diabetes center, Seoul, Korea, Republic of
Comparison of Analgesic Effects According to Patient-controlled Epidural Analgesia Modes in Patients Undergoing Open Gastrectomy
Not Applicable
- Conditions
- Open Gastrectomy With Gastric Cancer
- Interventions
- Device: Conventional modeDevice: Apply CIPKA mode
- First Posted Date
- 2018-02-12
- Last Posted Date
- 2019-01-15
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 76
- Registration Number
- NCT03430440
- Locations
- 🇰🇷
Severance Hospital, Seoul, Korea, Republic of
Assessment of Change in Atherosclerotic Plaque by Serial CCTA
- Conditions
- Coronary Artery DiseaseHydroxymethylglutaryl-CoA Reductase InhibitorsCoronary Arteriosclerosis
- First Posted Date
- 2018-01-30
- Last Posted Date
- 2018-06-29
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 400
- Registration Number
- NCT03414840
- Locations
- 🇰🇷
Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of
Effects of MCDG Oil on Postprandial Lipid Metabolism
Not Applicable
Completed
- Conditions
- HyperlipidemiasTriglycerides High
- Interventions
- Dietary Supplement: MCDG oilDietary Supplement: LCT oil
- First Posted Date
- 2018-01-30
- Last Posted Date
- 2018-01-30
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 28
- Registration Number
- NCT03415568
- Locations
- 🇰🇷
Laboratory of Clinical Nutrigenetics/Nutrigenomics, Yonsei University., Seoul, Korea, Republic of
Inosine 5'-Monophosphate to Raise of Serum Uric Acid Level in Patients With Multiple System Atrophy: a Multi-center, Randomized Controlled, Double Blind, Parallel Assigned Clinical Trial
Phase 2
Completed
- Conditions
- Multiple System Atrophy
- Interventions
- Drug: 1) Inosine 5'-monophosphateDrug: Placebo
- First Posted Date
- 2018-01-18
- Last Posted Date
- 2019-07-08
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 43
- Registration Number
- NCT03403309
- Locations
- 🇰🇷
Department of Neurology, Yonsei University College of Medicine, Seoul, Seou, Korea, Republic of
A Validation Study of Relationships Among Genomic Gene Expression Profile, Prognosis and Prediction of Adjuvant Chemotherapy Benefit With Capecitabine and Oxaliplatin in Gastric Cancer Stage II and III (6th AJCC) Patients After D2 Surgery (CLASSIC)
Completed
- Conditions
- Stage II-III Gastric Cancer
- Interventions
- Genetic: nProfiler I Stomach Cancer Assay Kit
- First Posted Date
- 2018-01-18
- Last Posted Date
- 2018-01-18
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 640
- Registration Number
- NCT03403296
- Locations
- 🇰🇷
Department of Surgery, Yonsei University College of Medicine, Seoul, Korea, Republic of
A Study on Accuracy Improvement of Repeated Measure Uroflowmetry- Electromyography
Not Applicable
- Conditions
- Enuresis
- Interventions
- Biological: Uroflowmetry(Group B)Biological: Uroflowmetry-Combining electromyography with uroflowmetry (Group C)Biological: Combining electromyography with uroflowmetry (group A)
- First Posted Date
- 2018-01-17
- Last Posted Date
- 2019-01-16
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 51
- Registration Number
- NCT03399877
- Locations
- 🇰🇷
Department of Urology,, Seoul, Korea, Republic of
Long Term Evaluation and Management of Atrial Fibrillation in Pacemaker Patients
Not Applicable
Not yet recruiting
- Conditions
- Permanent Pacemaker Implantation
- Interventions
- First Posted Date
- 2018-01-17
- Last Posted Date
- 2019-08-29
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 135
- Registration Number
- NCT03401593
- Locations
- 🇰🇷
Division of Cardiology, Yonsei University Health System, Yonsei University College of Medicine, Seoul, Korea, Republic of
A Study of LDK378 in Patients With Non-small Cell Lung Cancer Harboring ROS1 Rearrangement
Phase 2
- Conditions
- Non-small Cell Lung Cancer Harboring ROS1 Rearrangement
- Interventions
- Drug: LDK378(Ceritinib)
- First Posted Date
- 2018-01-16
- Last Posted Date
- 2019-01-11
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 46
- Registration Number
- NCT03399487
- Locations
- 🇰🇷
Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath